This report presents a strategic analysis of Brazil's Over the Counter (OTC) Pharmaceuticals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies, and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about Brazil's Over the Counter (OTC) Pharmaceuticals Market, offering unmatched value, accuracy, and expert insights.

1. Brazil OTC
Pharmaceuticals
Market Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2021 – 2030F)

2. This report presents a strategic analysis of the Brazil OTC
Pharmaceutical market and a forecast for its development in the medium
and long term. It provides a comprehensive overview of the market value,
dynamics, segmentation, characteristics, main players, trends and insights,
growth and demand drivers, challenges & future outlook, etc. This is one of
the most comprehensive reports about the Brazil OTC Pharmaceutical
market, and offers unmatched value, accuracy, and expert insights

3. Table of
Contents
• Market Overview
• Growth Drivers & Restraints
• Major Types of OTC Drugs
• Market Segmentation
• Major Products Market Share
• Competitive Landscape
• Key Company Profiles
• Healthcare Policies & Regulatory Framework
• Notable Deals
• Strategic Recommendations

4. 4
4 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
Table of Contents
1. Brazil OTC pharmaceuticals market overview………………………..………………………………………………………………………….7
1.1 Market size and forecast
2. Market growth drivers and restraints ………………………………………………………..……………..….…………………………………9
2.1 Market growth Drivers
2.1.1 Accessibility of OTC drugs
2.1.2 Increasing Product Innovation
2.1.3 Switching of Rx Drugs to OTC
2.2 Market Restrains
2.2.1 Irrational use of medicines due to self-diagnosis / misdiagnosis
2.2.2 Drug abuse, possibilities of drug addiction
3. Major types of OTC drugs…………..…………….….……..………………………………….…………………………………………........….15
3.1 Analgesics
3.2 Cough, Cold and Flu Products
3.3 Vitamins and Minerals
3.4 Skincare Products
3.5 Anti Allergic Drugs (Antihistamines)
3.6 Gastrointestinal Products
3.7 Ophthalmic Products
3.8 Sleep Aid Products

5. 5
5 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
Table of Contents (continued)
4. OTC pharmaceuticals market segmentation……………………………………….…………....………………....…………………........….….18
4.1 By Product Type
4.2 By Formulation
4.3 By Distribution Channel
5. Major products market share……………………………………………………….………………...…….……………………………..…………23
5.1 Market analysis, insights and forecast - By revenue
6. Competitive Landscape…………………………………………………………………………………………………….……………………...….25
6.1 Major players
6.2 Key Players by Revenue Growth and Market Share
7. Key Company Profiles (Company Overview, Product & Services, Strategies & Financials ) ….…………………………….…............27
7.1 Abbott Laboratories
7.2 Natura &Co
7.3 Sanofi-Aventis SA
7.4 Glenmark Pharmaceuticals Ltd.
7.5 Johnson & Johnson Services Inc
7.6 LIBBS Farmaceutica Ltd
7.7 GlaxoSmithKline plc
7.6 Takeda Pharmaceuticals

6. 6
6 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
Table of Contents (continued)
8. Healthcare policies and regulatory landscape………………………………….………………………………………………………...………36
8.1 Policy changes and Reimbursement scenario
9. Notable Deals…………………………………………………………………………………………….……………………………………………..39
9.1 Notable recent deals and partnerships
10. Strategic recommendations…………………………………………………………………………………………………..………..……….…..42

7. Brazil OTC Pharmaceutical Market Analysis
1. Overview

8. 8 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
Brazil OTC Pharmaceuticals market analysis
(Current and Forecast)
Brazil OTC Pharmaceuticals Market Size (Bn)
2021-2030F
Key Analysis
$3.381
xx
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
▪ Brazil OTC Pharmaceuticals Market size stood at around US$
3.381 Bn in 2021 and is projected to reach US$ XX Bn by
2030, exhibiting a CAGR of 5.7% during the forecast period
▪ The market's largest segment is the segment Analgesics with
a market volume of US$1.038 Bn in 2022
▪ In the OTC Pharmaceuticals market, 24.2% of total revenue
will be generated through online sales by 2022
Sample

9. Brazil OTC Pharmaceutical Market Analysis
2. Growth Drivers & Restraints

10. 10 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
2. Market Growth Drivers and Restrains
Accessibility of OTC
drugs
Switching of Rx Drugs to
OTC
Increasing Product
Innovation
Irrational use of medicines due
to self-diagnosis / misdiagnosis
Drug abuse, possibilities of
drug addiction

11. 11 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
2.1 Market Growth Drivers
New channels of accessibility in emerging markets in retail outlets, supermarkets are contributing to the growth of
the Brazil OTC pharmaceuticals market in the emerging economies
Sample
2.1.1 Accessibility of OTC drugs
Allowing some medications, under specific circumstances, to be available without the necessity of seeing a
prescriber may allow prescribers to spend more time with seriously ill patients. The FDA is considering allowing the
establishment of some medications (that are now available by prescription) to be available OTC, after use of specific
electronic diagnostic measures or algorithms; or after consultation with a pharmacist; or by other additional means

12. 12 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
Market Growth Drivers (continued)
2.1.2 Product Innovations
Product innovation, high penetration in emerging markets, a favorable regulatory framework, and the trend for
pharmaceutical companies to shift from prescription to OTC are the growth drivers of the OTC market of Brazil
Sample
With technological advancements and product innovation, SMEs are expanding their market presence by introducing
new products at lower prices

13. 13 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
Market Growth Drivers (continued)
2.1.3 Switching of Rx Drugs to OTC
Sample
Several companies have been opting for several innovative marketing strategies, to capture a market share as high
as possible. Companies are using various strategies to switch to Rx drugs to OTC drugs
Sample
Key industry players are involved in R&D to develop and market new OTC drugs for various health conditions.
Hence patients are switching to new OTC drugs instead of Rx drug which will leading the OTC market in the Brazil

14. 14 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
2.2 Market Restraints
2.2.1 Probability of Substance Abuse 2.2.2 Drug abuse, possibilities of drug
addiction
Sample
▪ All OTC medication carries risk, primarily
risk of tolerance and dependence by
OTC painkillers
▪ High and more frequent doses of OTC
drugs can lead to phycological
dependence
▪ Drug abuse of antihistamines, sleep aids,
caffeine, ephedrine, pseudoephedrine,
antitussives and expectorants,
dextromethorphan, laxatives, anabolic
steroids, and sildenafil by teenagers is
one of the major challenge
▪ Consumption of wrong medication due to
incorrect self-diagnosis or misdiagnosis
may lead to severe complications and is
one of the key factor that may hinder the
market growth
▪ Many OTC cold and cough products
have led to medication errors and cause
adverse effects on the patient’s body

15. Brazil OTC Pharmaceutical Market Analysis
3. Major OTC Drugs

16. 16
16 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
4.1 Analgesics
▪ Analgesics are medications
that relieve pain
▪ Unlike medications used for
anesthesia during surgery,
analgesics don't turn off
nerves, change the ability to
sense your surroundings or
alter consciousness
4.2 Cough, Cold and
Flu Products
▪ There are lots of different
cold and cough medicines,
and they do different things:
Nasal decongestants -
unclog a stuffy nose
▪ Cough suppressants -
quiet a cough
▪ Expectorants - loosen
mucus in your lungs so
you can cough it up.
▪ Antihistamines - stop
runny noses and
sneezing
4.3 Vitamins and Minerals
▪ Vitamin and mineral rich
supplements have
medicinal properties which
offer healing benefits
apart from fulfilling daily
required nutrients. It helps
in building a strong
immune system against
common diseases
4.4 Skincare Products
▪ OTC dermatology drugs are
an accepted treatment for
many common medical
problems, including
musculoskeletal pain,
headaches, cold symptoms,
allergies, heartburn, and
dermatitis
Major OTC Drugs

17. 17
17 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
4.5 Anti Allergic Drugs
Sample
4.6 Gastrointestinal
Products
4.7 Ophthalmic Products
▪ Most over-the-counter (OTC)
ophthalmic drugs contain
humectants (substances that
help retain moisture),
lubricants, and electrolytes,
such as potassium which
help in providing extra
moisture to the eyes and can
be used as per the directions
given
4.8 Sleep Aid Products
Sample
Sample
Major OTC Drugs

18. 18
Brazil OTC Pharmaceutical Market Analysis
4. Market Segmentation

19. 19
19 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
OTC Market Segmentation
By Product Type By Formulation By Distribution Channel
Analgesics Cough, Cold and
Flu , Anti Allergic Products
Vitamins and Minerals
Dermatological Products
Gastrointestinal Products
Sleep Aid Products
Ophthalmic Products
Weight Loss/Diet Products
Tablets (Oral)
Liquids (Oral)
Ointments (Topical)
Sprays (Topical)
Pharmacies
Supermarkets
Convenience Stores
Online Stores
Market Segmentation

20. 20
20 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
4.1 OTC Pharmaceuticals Market Segmentation: By Product Type
▪ By Product type Brazil OTC drugs segments the market
intoAnalgesics Cough, Cold and Flu Products, Vitamins
and Minerals, Dermatological Products, Gastrointestinal
Products, Ophthalmic Products, Sleep Aid Products,
Weight Loss/Diet Products, Others
Key Insights
Brazil OTC Market Share by Product Type 2022
Analgesics,Cough & Cold, Anti Allergic
Dermatological Products
Ophthalmic Products
Weight Loss/Diet Products
Vitamins and Minerals
Gastrointestinal Products
Sleep Aid Products
Sample

21. 21
21 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
▪ Brazil OTC Market is segmented into Tablets,
Liquids, Ointments, and Sprays by formulation
Tablets Liquids Ointments Corticosteroids
Brazil OTC Market Share By Formulation 2022 Key Insights
4.2 OTC Pharmaceuticals Market Segmentation: By Formulation
Sample

22. 22
22 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
▪ The Brazil OTC Market is segmented into Online
Pharmacies, Supermarkets, Convenience Stores, and
Online Stores by the Distribution Channels
▪ Hospitals remain the primary point of access for
healthcare services, and the distribution of consumer
health products is only permitted through pharmacies
Pharmacies Supermarkets ConvenienceStores Online Stores
Brazil OTC Market Share by Distribution Channel 2022 Key Insights
4.3 OTC Pharmaceuticals Market Segmentation: By Distribution Channels

23. 23
Brazil OTC Pharmaceutical Market Analysis
5. Major Product Market Share

24. 24 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
5.1 Market Analysis, Insights and Forecast- By Major Brands
Key Insights
Market Analysis for Major OTC Pharmaceuticals Brands (2022
Brand 1 Brand 2 Brand 3 Brand 4 Brand 5
Get full report for access

25. Brazil OTC Pharmaceutical Market Analysis
6. Competitive Landscape

26. 26 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
6.1 Competitive Landscape: Key Players Revenue
(Current and Forecast)
Major Market Revenue of Top Companies in Market ($Mn)
2021 2022F 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Abbott Laboratories $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Natura &Co $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Sanofi-Aventis SA $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Glenmark
Pharmaceuticals
Ltd.
$xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Johnson & Johnson
Services Inc
$xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
LIBBS Farmaceutica
Ltd
$xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
GlaxoSmithKline plc $xx $xx $xx $xx $xx $xx $xx $xx $xx $xx
Takeda
Pharmaceuticals
$xx $xx $xx $xx $xx $xx $xx $xx $xx $xx

27. Brazil OTC Pharmaceutical Market Analysis
7. Key Company Profiles

28. 28 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
7.1 Abbott Laboratories
Company Name: Abbott Laboratories
Year of Establishment: 1888
Headquarter: Chicago, Illinois, United States
Total Revenue: $XX Bn
Website: http://www.abbott.com/
Company at a Glance
Company Overview
Sample

29. 29 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
7.2 Natura &Co
Company Name: Natura &Co
Year of Establishment: 1969
Headquarter: São Paulo, Brazil
Total Revenue: $XX Bn
Website: https://www.naturaeco.com/
Company at a Glance
Company Overview
Sample

30. 30 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
7.3 Sanofi
Company Name: Sanofi
Year of Establishment: 2004
Headquarter: Paris, France
Total Revenue: $XX Bn
Website: http://www.sanofi.com/
Company at a Glance
Company Overview
Sample

31. 31 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
7.4 Glenmark Pharmaceuticals Ltd.
Company Name: Glenmark
Pharmaceuticals Ltd.
Year of Establishment: 1977
Headquarter: Mumbai, India
Total Revenue: $XX Bn
Website: glenmarkpharma.com
Company at a Glance
Company Overview
Sample

32. 32 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
7.5 Johnson & Johnson
Company Name: Johnson & Johnson
Year of Establishment: 1886
Headquarter: New Brunswick, New Jersey,
United States
Total Revenue: $XX Bn
Website: www.jnj.com
Company at a Glance
Company Overview
Sample

33. 33 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
7.6 LIBBS Farmaceutica Ltd
Company Name: LIBBS Farmaceutica Ltd
Year of Establishment: 1958
Headquarter: São Paulo, State of São Paulo,
Brazil
Total Revenue: $xx Bn
Website: www.libbs.com.br/
Company at a Glance
Company Overview
Sample

34. 34 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
7.7 GlaxoSmithKline plc
Company Name: GlaxoSmithKline plc
Year of Establishment: 2000
Headquarter: Brentford, United Kingdom
Total Revenue: $XX Bn
Website: www.gsk.com
Company at a Glance
Company Overview
Sample

35. 35 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
7.8 Takeda Pharmaceuticals
Company Name: Takeda Pharmaceuticals
Year of Establishment: 1781
Headquarter: Tokyo, Japan
Total Revenue: $XX Bn
Website: www.takeda.com/
Company at a Glance
Company Overview
Sample

36. Brazil OTC Pharmaceutical Market Analysis
8. Healthcare Policy and Regulatory Landscape

37. 37 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
8.1 Regulatory Landscape: Healthcare Policy
▪ The Brazilian Health Surveillance Agency (ANVISA) published Collegiate Board Resolution 98/2016. The Resolution establishes
new rules for the inclusion of certain drugs as over-the-counter drugs (OTCs)
▪ The new rules allow the inclusion of new drugs to the list of OTCs, setting out seven conditions concerning the following:
• Time of marketing
• Safety
• Identifiable symptoms
• Time of use
• Management by the patient
• Low potential of risk
• Low addiction
▪ The Resolution seeks to provide clear rules to pharmaceutical companies that wish to submit applications for the reclassification of
their drugs as OTCs before ANVISA. A number of procedures must be followed after ANVISA's classification of the drug as an
OTC: for example, the marketing authorisation holder must submit a "request for sale category change" and a "notification for
leaflet information change“
Get full report for access

38. 38 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
Successful market access
▪ Entering the pharmaceutical market in Brazil is complex and requires long-term planning. First, the company must determine
which commercial strategy it will adopt in Brazil (import or manufacture of drugs)
▪ Then, it must establish itself in Brazil by acquiring and adapting to a location or establishing a partnership with a competent local
company
▪ The next step is to obtain sanitary licenses prior to the activity and mandatory before ANVISA and Local Sanitary Surveillance,
such as an Operating Permit, Local License and Certificates of Good Practice
▪ In possession of these authorizations, the company may then apply for the MA of the drug. Once granted the MA of the drug by
ANVISA, the company must then request the drug capped price before COUNCIL OF MINISTERS of the DRUG MARKET
REGULATION CHAMBER (CMED) .With the fixing of the price, the company may sell the product on the Brazilian market
▪ Technical and legal assistance is recommended during the entire process of establishing the company in Brazil, in particular, to
adapt physical facilities, prepare technical documents, and maintain a good relationship with the authorities, while always abiding
by legislation and remaining helpful and proactive

39. Brazil OTC Pharmaceutical Market Analysis
9. Notable Deals

40. 40 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
In June 2022, Glenmark Pharmaceuticals Ltd has acquired the approved generic versions of certain over-the-counter
drugs from Wockhardt Ltd in the United States. The acquisition by the company’s fully-owned subsidiary Glenmark
Pharmaceuticals Inc, includes the approved abbreviated new drug applications (ANDAs) for famotidine tablets, 10 mg
and 20 mg used to treat and prevent ulcers in the stomach and intestine
Glenmark Pharmaceuticals Ltd has acquired the approved generic
versions of certain over-the-counter drugs from Wockhardt Ltd
Glenmark Pharmaceuticals Ltd Wockhardt Ltd
Sample

41. 41 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
GSK reaches agreement with Novartis to acquire full ownership of
consumer healthcare business
GlaxoSmithKline plc Novartis
Sample Sample Sample

42. Brazil OTC Pharmaceutical Market Analysis
10. Conclusion

43. 43 A Sample Report on Brazil OTC Pharmaceuticals market I Confidential
Strategic Recommendations
▪ OTC drugs are characterized by strong brand loyalty compared to general consumer goods, retailers with
powerful sales capabilities are expected to strengthen the market presence of their private labels in the future
▪ Companies with solid sales capabilities and expertise could play a part in expanding the sales channels of OTC
drugs that have strong brand recognition. With the influence of online pharmacies spreading, even the majors
behind leading brands are rushing to strengthen their sales capabilities.
▪ Companies in other industries will likely discover new business opportunities in the unique characteristics of OTC
drugs and trends in the industry, which is yielding new business opportunities
Personalized medicine for osteoarthritis
Get full report for access

44. Methodology & Scope

45. 45 A Sample Report on Brazil OTC Pharmaceutical Market Analysis I Confidential
Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

46. 46 A Sample Report on Brazil OTC Pharmaceutical Market Analysis I Confidential
Analysis Methodology
Our Analysis Methodology involves three critical stages:
Primary
Research
Secondary
Research
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Data Collection
Market Data Analysis
& Statistical Model
Interpretation &
Presentation

47. 47 A Sample Report on Brazil OTC Pharmaceutical Market Analysis I Confidential
Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

48. 48 A Sample Report on Brazil OTC Pharmaceutical Market Analysis I Confidential
Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

49. 2021
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

50. The report is prepared
using a proven
methodology and
insightful research
Reliable
The data is prepared by
a team of highly qualified
& experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything you
would need to know
about the market
including market size,
competitive analysis &
much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com

51. About

52. www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Lifesciences Market
Research Reports you
can trust

53. Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get Insights to take
informed Business
Decisions
www.insights10.com

54. Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices

55. Our
Services
1
2
3
4
5
6
10
9
8
7
Market Research Reports
Customized Reports
Primary Research
Database Services
Full-Time Engagement
Conference Coverage
Competitive Intelligence
Strategic Research Projects Regulatory Compliance
Report Subscription Services

56. Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com

57. Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com

58. Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

59. Mukesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market
research & marketing professional
with a progressive experience of over
20 years in Life Sciences, Pharma
and Medical Device sectors. With an
in-depth understanding of primary
research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare
& completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Atharva is a B.Tech (Biotechnology) and
MBA in Hospital and Health Management
with 2 years of experience working in
consulting and project management in
healthcare and Non-Government
organizations. Conducted
comprehensive research and market
sizing exercise to understand the
business potential for modern digital
trends. Conducted comprehensive
secondary research for the subjects
including the UK Mobility Aids market,
Brazil’s Ophthalmology market, etc.
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Atharva Bahad
Consultant
Project Leadership Team

60. 7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more

61. Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
Whatsapp: (+91) 931 639 7935
We would be happy to help.